Pulmonary Hypertension Association's 2022 International Conference Scientific Sessions Overview.

29 The TRACE trial randomized patients to selexipag versus placebo and used accelerometry for 24 weeks to assess the mean difference in activity time and step count, with results that favored the selexipag group, but did not reach statistical significance. 30 Looking into other disease literature, PHYSACTO PROactive study in chronic obstructive pulmonary disease (COPD) used scores that combine patient‐reported outcomes with accelerometer‐derived data to assess patient physical activity, and these scores are being used as endpoints in the COPD literature.

also in 111,027 other papers

45 Before COVID‐19 pandemic, telemedicine was already experiencing a significant trend upward, although this did not compare to the massive increase in telemedicine uptake seen during the pandemic in 2020.

also in 9,775 other papers